Aazami Hossein, DehghanBanadaki Hojat, Ejtahed Hanieh-Sadat, Fahimfar Noushin, Razi Farideh, Soroush Ahmad-Reza, Hasani-Ranjbar Shirin, Pasalar Parvin, Ahmadi Badi Sara, Siadat Seyed-Davar, Larijani Bagher
Metabolic Disorders Research Center, Endocrinology and Metabolism Molecular-Cellular Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
Scientometrics Department, FarIdea Company, Tehran, Iran.
J Diabetes Metab Disord. 2020 Jan 15;19(1):163-177. doi: 10.1007/s40200-020-00488-2. eCollection 2020 Jun.
To introduce bibliometric features of Iranian documents on microbiota and to provide descriptive information about retrieved documents related to the medical sciences and documents utilizing molecular techniques for microbiota detection.
This is a descriptive bibliometric study of all Iranian documents on microbiota in any language that were indexed in Scopus before 7 September 2019. We assessed the research performance through statistical analysis of the bibliometric indicators, including number of publications, citations, institutions and journals activities, co-citations and bibliographic couplings, and network analysis of co-authorships, countries' collaborations, terms and keywords.
We extracted 425 relevant documents, 260 of which pertain to the medical sciences. The most focused microbiota modulating interventions and diseases in 33 clinical trials are 'synbiotics' ( = 8) and 'probiotics' (n = 8), and 'Obesity' ( = 3) and 'non-alcoholic fatty liver disease' (n = 3), respectively. During the last decade, Iranian microbiota publications have increasingly grown with a constant upward slope, particularly in the area of medical sciences after 2016. Citation counting reveals that originals and reviews have been cited 4221 times, with an average 10.76 citations and H-index of 34. The most significant performance in publishing Iranian microbiota documents belongs to 'Tehran University of Medical Sciences' as the active institution ( = 89 publications) and the supporting sponsor ( = 19), 'Microbial Pathogenesis' as the productive journal ( = 12), 'Seidavi A' as the most authorships (n = 19), and 'the United States' as the collaborative country ( = 46).
The qualitative and quantitative information of this study will be a practical guidance for future study planning and policy-decision making.
介绍伊朗关于微生物群的文献计量学特征,并提供与医学科学相关的检索文献以及利用分子技术检测微生物群的文献的描述性信息。
这是一项描述性文献计量学研究,研究对象为2019年9月7日前在Scopus中索引的所有语言的伊朗微生物群文献。我们通过对文献计量指标进行统计分析来评估研究绩效,这些指标包括出版物数量、引用次数、机构和期刊活动、共被引和文献耦合,以及对共同作者、国家合作、术语和关键词进行网络分析。
我们提取了425篇相关文献,其中260篇与医学科学相关。在33项临床试验中,最受关注的微生物群调节干预措施和疾病分别是“合生元”(n = 8)和“益生菌”(n = 8),以及“肥胖症”(n = 3)和“非酒精性脂肪性肝病”(n = 3)。在过去十年中,伊朗微生物群出版物呈持续上升趋势,数量不断增加,特别是在2016年后的医学科学领域。引文计数显示,原创文章和综述被引用了4221次,平均每篇被引用10.76次,H指数为34。发表伊朗微生物群文献表现最为突出的是“德黑兰医科大学”,它是活跃机构(n = 89篇出版物)和主要资助者(n = 19),“微生物发病机制”是高产期刊(n = 12),“赛达维A”是作者数量最多的人(n = 19),“美国”是合作最多的国家(n = 46)。
本研究的定性和定量信息将为未来的研究规划和政策决策提供实际指导。